Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae.

Antimicrobial Agents and Chemotherapy
T S LucierP C Hu

Abstract

Erythromycin is the drug of choice for treatment of Mycoplasma pneumoniae infections due to its susceptibility to low levels of this antibiotic. After exposure of susceptible strains to erythromycin in vitro and in vivo, mutants resistant to erythromycin and other macrolides were isolated. Their phenotypes have been characterized, but the genetic basis for resistance has never been determined. We isolated two resistant mutants (M129-ER1 and M129-ER2) by growing M. pneumoniae M129 on agar containing different amounts of erythromycin. In broth dilution tests both strains displayed resistance to high levels of several macrolide-lincosamide-streptogramin B (MLS) antibiotics. In binding studies, ribosomes isolated from the resistant strains exhibited significantly lower affinity for [14C]erythromycin than did ribosomes from the M129 parent strain. Sequencing of DNA amplified from the region of the 2S rRNA gene encoding domain V revealed an A-to-G transition in the central loop at position 2063 of M129-ER1 and a similar A-to-G transition at position 2064 in M129-ER2. Transitions at homologous locations in the 23S rRNA from other organisms have been shown to result in resistance to MLS antibiotics. Thus, MLS-like resistance can occur ...Continue Reading

References

Nov 18, 1977·Molecular & General Genetics : MGG·D Pardo, R Rosset
May 1, 1977·The Journal of Experimental Medicine·P C HuJ B Baseman
Jul 1, 1991·Antimicrobial Agents and Chemotherapy·R Leclercq, P Courvalin
Sep 1, 1989·Diagnostic Microbiology and Infectious Disease·G H CassellL B Duffy
Aug 1, 1987·Journal of Bacteriology·M C Roberts, G E Kenny
Sep 1, 1986·The Journal of Antimicrobial Chemotherapy·T Stopler, D Branski
Jan 1, 1988·Nucleic Acids Research·R R Gutell, G E Fox
Feb 1, 1986·Antimicrobial Agents and Chemotherapy·M C Roberts, G E Kenny
Jul 1, 1967·American Journal of Epidemiology·R I SlotkinF W Denny
Jan 1, 1971·The Journal of Infectious Diseases·F W DennyW P Glezen
Mar 1, 1970·The Journal of Pediatrics·Y NiituM Horikawa
May 25, 1967·The New England Journal of Medicine·C B SmithR M Chanock
Jan 1, 1984·Annual Review of Biochemistry·H F Noller
Jun 11, 1984·Nucleic Acids Research·C D SigmundE A Morgan
Sep 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·C D Sigmund, E A Morgan
Jan 8, 1981·The New England Journal of Medicine·G H Cassell, B C Cole
Jun 1, 1980·The Journal of Infection·D Taylor-RobinsonG L Asherson
Mar 1, 1995·Antimicrobial Agents and Chemotherapy·B Weisblum
Apr 1, 1994·Antimicrobial Agents and Chemotherapy·K IshidaK Tomono
Feb 1, 1994·Antimicrobial Agents and Chemotherapy·A MeierE C Böttger
Aug 1, 1993·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C BébéarB de Barbeyrac
Feb 1, 1947·The Review of Scientific Instruments·G C BALDWINA J HARTZLER

❮ Previous
Next ❯

Citations

May 9, 1998·International Journal of Antimicrobial Agents·M C Roberts
Aug 2, 2002·Molecular Cell·Jeffrey L HansenThomas A Steitz
Mar 16, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C KrasemannG Tillotson
Sep 14, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Takafumi OkadaKimiko Ubukata
Apr 5, 2000·The Journal of Antimicrobial Chemotherapy·P M FurneriL S Roccasalva
Sep 8, 2009·Respirology : Official Journal of the Asian Pacific Society of Respirology·Rie IsozumiKoya Ariyoshi
Nov 15, 2011·Respirology : Official Journal of the Asian Pacific Society of Respirology·Yasuhiro KawaiKazunobu Ouchi
May 16, 2012·Antimicrobial Agents and Chemotherapy·Yong WangHongbin Song
Jun 30, 2010·Antimicrobial Agents and Chemotherapy·Stephanie A ChisholmCatherine A Ison
Jul 23, 2008·Antimicrobial Agents and Chemotherapy·Bernard J WolffJonas M Winchell
May 30, 2013·Antimicrobial Agents and Chemotherapy·Yasuhiro KawaiKazunobu Ouchi
Mar 28, 2007·Antimicrobial Agents and Chemotherapy·Tsutomu YamazakiMasahiro Takahata
Dec 25, 2012·Antimicrobial Agents and Chemotherapy·Fei ZhaoJianzhong Zhang
Dec 20, 2000·Antimicrobial Agents and Chemotherapy·B Vester, S Douthwaite
Dec 20, 2000·Antimicrobial Agents and Chemotherapy·M TakahataH Narita
Apr 18, 2002·Antimicrobial Agents and Chemotherapy·Peter SanderErik C Böttger
Dec 25, 2002·Antimicrobial Agents and Chemotherapy·Ken B WaitesLynn B Duffy
Nov 25, 2004·Antimicrobial Agents and Chemotherapy·Mayumi MatsuokaTsuguo Sasaki
Feb 26, 2004·Antimicrobial Agents and Chemotherapy·B Helen JostStephen J Billington
Mar 30, 2004·Antimicrobial Agents and Chemotherapy·O Y MisyurinaV M Govorun
May 27, 2005·Antimicrobial Agents and Chemotherapy·Miyuki MorozumiKimiko Ubukata
Jan 27, 2006·Antimicrobial Agents and Chemotherapy·Satowa SuzukiTsuguo Sasaki
Oct 19, 2004·Clinical Microbiology Reviews·Ken B Waites, Deborah F Talkington
Jun 2, 2012·BMC Infectious Diseases·Naoyuki MiyashitaUNKNOWN Atypical Pathogen Study Group
Nov 1, 2008·American Journal of Clinical Dermatology·João Figueira-CoelhoJosé António Malhado
Apr 30, 2011·Future Microbiology·Cécile BébéarOlivia Peuchant
Oct 1, 2014·The Journal of Infection·Emiel B M SpuesensAnnemarie M C van Rossum
Nov 10, 2009·European Journal of Pediatrics·Shintaro KamizonoMitsuo Narita
Oct 19, 2012·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Ryoichi Hamasuna
Aug 3, 2010·International Journal of Antimicrobial Agents·Naoyuki MiyashitaKazunobu Ouchi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.